Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma Q Song, J Shang, Z Yang, L Zhang, C Zhang, J Chen, X Wu Journal of translational medicine 17, 1-11, 2019 | 151 | 2019 |
Therapeutic cancer vaccines: From initial findings to prospects Q Song, C Zhang, X Wu Immunology letters 196, 11-21, 2018 | 116 | 2018 |
The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC Q Song, X Zhang Biomedicines 10 (3), 524, 2022 | 89 | 2022 |
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma Q Song, X Zhang, W Liu, H Wei, W Liang, Y Zhou, Y Ding, F Ji, ... Journal of hepatology 79 (6), 1352-1365, 2023 | 79 | 2023 |
Construction of immune‐related risk signature for renal papillary cell carcinoma Z Wang, Q Song, Z Yang, J Chen, J Shang, W Ju Cancer medicine 8 (1), 289-304, 2019 | 50 | 2019 |
Transcription factor RUNX3 promotes CD8+ T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment Q Song, J Shang, C Zhang, J Chen, L Zhang, X Wu Journal of cellular biochemistry 121 (5-6), 3208-3220, 2020 | 32 | 2020 |
Identification of prognostic signatures for predicting the overall survival of uveal melanoma patients M Xue, J Shang, B Chen, Z Yang, Q Song, X Sun, J Chen, J Yang Journal of Cancer 10 (20), 4921, 2019 | 32 | 2019 |
Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types C Zhang, J Chen, Q Song, X Sun, M Xue, Z Yang, J Shang International Immunopharmacology 85, 106633, 2020 | 29 | 2020 |
MicroRNA-10b and the clinical outcomes of various cancers: A systematic review and meta-analysis Q Huang, Q Song, W Zhong, Y Chen, L Liang Clinica Chimica Acta 474, 14-22, 2017 | 28 | 2017 |
Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients Q Song, J Shang, C Zhang, L Zhang, X Wu Journal of cancer research and clinical oncology 145, 737-746, 2019 | 24 | 2019 |
Identification of lung adenocarcinoma specific dysregulated genes with diagnostic and prognostic value across 27 TCGA cancer types J Shang, Q Song, Z Yang, D Li, W Chen, L Luo, Y Wang, J Yang, S Li Oncotarget 8 (50), 87292, 2017 | 21 | 2017 |
Analysis of PD-1 related immune transcriptional profile in different cancer types J Shang, Q Song, Z Yang, X Sun, M Xue, W Chen, J Yang, S Wang Cancer cell international 18, 1-11, 2018 | 19 | 2018 |
Development of a nomogram for preoperative prediction of lymph node metastasis in non-small cell lung cancer: a SEER-based study C Zhang, Q Song, L Zhang, X Wu Journal of Thoracic Disease 12 (7), 3651, 2020 | 9 | 2020 |
Effect of clinicopathologic features on survival of patients with thymic carcinomas and thymic neuroendocrine tumors: A population-based analysis Q Song, LL Zhang, Y Qi, KL Xing, XH Wu Current Problems in Cancer 43 (5), 411-420, 2019 | 9 | 2019 |
CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: evidence from original research and literature C Hu, X Dong, J Wu, F Xiao, J Shang, L Liu, Y Yang, D Luo, Q Li, Q Song, ... Oncotarget 8 (19), 30888, 2017 | 9 | 2017 |
Shorter GGN repeats in androgen receptor gene would not increase the risk of prostate cancer J Li, F Xiao, Y Zhang, A Lan, Q Song, R Zhang, K Gu, P Chen, Z Li, ... Technology in Cancer Research & Treatment 16 (2), 159-166, 2017 | 8 | 2017 |
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis X Li, S Shang, M Wu, Q Song, D Chen Cancer Letters, 217096, 2024 | 7 | 2024 |
ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients J Yang, J Shang, Q Song, Z Yang, J Chen, Y Yu, L Shi BMC cancer 20, 1-6, 2020 | 2 | 2020 |
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy Y Zhang, M Xie, J Wen, C Liang, Q Song, W Liu, Y Liu, Y Song, HCH Lau, ... Gut, 2024 | | 2024 |